NCT00306241View on ClinicalTrials.gov

A Study to Evaluate the Immunogenicity and Safety of GSK Biologicals' HPV Vaccine in Healthy Women Aged 18-35 Years

PHASE3CompletedINTERVENTIONAL

Enrollment

300

Participants

Timeline

Start Date

March 31, 2006

Primary Completion Date

June 30, 2007

Study Completion Date

June 30, 2007

Conditions

Infections, Papillomavirus

Interventions

BIOLOGICAL

HPV-16/18 L1 VLP AS04

Trial Locations (1)

Unknown

GSK Investigational Site, Hong Kong

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY